GB9723078D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- GB9723078D0 GB9723078D0 GBGB9723078.3A GB9723078A GB9723078D0 GB 9723078 D0 GB9723078 D0 GB 9723078D0 GB 9723078 A GB9723078 A GB 9723078A GB 9723078 D0 GB9723078 D0 GB 9723078D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9723078.3A GB9723078D0 (en) | 1997-10-31 | 1997-10-31 | Chemical compounds |
EP98950227A EP1027335A1 (en) | 1997-10-31 | 1998-10-30 | Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
JP2000518950A JP2001521924A (en) | 1997-10-31 | 1998-10-30 | Ortho-hydroxypyridinone derivatives as iron chelators and antioxidants |
PCT/GB1998/003244 WO1999023075A1 (en) | 1997-10-31 | 1998-10-30 | Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
AU96380/98A AU9638098A (en) | 1997-10-31 | 1998-10-30 | Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9723078.3A GB9723078D0 (en) | 1997-10-31 | 1997-10-31 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9723078D0 true GB9723078D0 (en) | 1998-01-07 |
Family
ID=10821419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9723078.3A Ceased GB9723078D0 (en) | 1997-10-31 | 1997-10-31 | Chemical compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1027335A1 (en) |
JP (1) | JP2001521924A (en) |
AU (1) | AU9638098A (en) |
GB (1) | GB9723078D0 (en) |
WO (1) | WO1999023075A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1006108A1 (en) * | 1998-12-01 | 2000-06-07 | Cerebrus Pharmaceuticals Limited | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers |
EP1006112A1 (en) * | 1998-12-01 | 2000-06-07 | Cerebrus Pharmaceuticals Limited | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers |
ES2421511T3 (en) | 2001-12-21 | 2013-09-03 | X Ceptor Therapeutics Inc | LXR modulators |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
US6825204B2 (en) | 2002-02-05 | 2004-11-30 | Bristol-Myers Squibb Company | N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
AU2003282337B2 (en) * | 2002-11-07 | 2009-07-16 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
MX2012010188A (en) * | 2010-03-04 | 2012-10-03 | Merck Sharp & Dohme | Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders. |
CN110407741B (en) * | 2018-04-26 | 2023-03-21 | 启元生物(杭州)有限公司 | Anti-inflammatory compound and preparation and application thereof |
CN111170936B (en) | 2020-01-19 | 2021-01-01 | 杭州泽德医药科技有限公司 | 3,4-Dihydroxy-N-(1'-benzyl-2'-hydroxyethyl)-2-methylpyridine chloride and its preparation and application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
US5336482A (en) * | 1991-12-05 | 1994-08-09 | The Du Pont Merck Pharmaceutical Company | Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones |
US5624901A (en) * | 1994-04-15 | 1997-04-29 | The Regents Of The University Of California | 3-hydroxy-2(1H)-pyridinone chelating agents |
ATE299135T1 (en) * | 1995-09-29 | 2005-07-15 | Novartis Pharma Gmbh | HYDROXYPYRIDINONE |
GB9625638D0 (en) * | 1996-12-10 | 1997-01-29 | Cenes Ltd | Therapeutic antioxidants for alzheimer's diease |
-
1997
- 1997-10-31 GB GBGB9723078.3A patent/GB9723078D0/en not_active Ceased
-
1998
- 1998-10-30 JP JP2000518950A patent/JP2001521924A/en not_active Withdrawn
- 1998-10-30 AU AU96380/98A patent/AU9638098A/en not_active Abandoned
- 1998-10-30 EP EP98950227A patent/EP1027335A1/en not_active Withdrawn
- 1998-10-30 WO PCT/GB1998/003244 patent/WO1999023075A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1027335A1 (en) | 2000-08-16 |
JP2001521924A (en) | 2001-11-13 |
WO1999023075A1 (en) | 1999-05-14 |
AU9638098A (en) | 1999-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9705361D0 (en) | Chemical compounds | |
GB9704208D0 (en) | Chemical compounds | |
GB9717804D0 (en) | Chemical compounds | |
GB9708530D0 (en) | Chemical compounds | |
GB9723078D0 (en) | Chemical compounds | |
GB9703201D0 (en) | Chemical compounds | |
GB9708119D0 (en) | Chemical compounds | |
GB9706707D0 (en) | Chemical compounds | |
GB9715768D0 (en) | Chemical compounds | |
GB9711994D0 (en) | Chemical compounds | |
GB9713731D0 (en) | Chemical compounds | |
GB9702998D0 (en) | Chemical compounds | |
GB9704182D0 (en) | Chemical compounds | |
GB9717279D0 (en) | Chemical compounds | |
GB9717796D0 (en) | Chemical compounds | |
GB9713490D0 (en) | Chemical compounds | |
GB9713410D0 (en) | Chemical compounds | |
GB9712270D0 (en) | Chemical compounds | |
GB9701305D0 (en) | Chemical compounds | |
GB9711712D0 (en) | Chemical compounds | |
GB9717795D0 (en) | Chemical compounds | |
GB9717794D0 (en) | Chemical compounds | |
GB9711708D0 (en) | Chemical compounds | |
GB9711143D0 (en) | Chemical compounds | |
GB9716961D0 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |